ConductScience.org, home

Paper32937743

Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study.

Caccese M and 12 others. Int J Mol Sci, 2020. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study. Papers, record 32937743. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32937743

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2020
PubMed
Publication types
Journal Article, Multicenter Study
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.01
iCite
Revised in PubMed
2024-03-29
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Caccese MMario
2Ius TTamarahttps://orcid.org/0000-0003-3741-0639
3Simonelli MMatteohttps://orcid.org/0000-0002-5264-1251
4Fassan MMatteohttps://orcid.org/0000-0001-6515-5482
5Cesselli DDanielahttps://orcid.org/0000-0002-0562-7852
6Dipasquale AAngelo
7Cavallin FFrancesco
8Padovan MMarta
9Salvalaggio AAlessandrohttps://orcid.org/0000-0002-1273-7566
10Gardiman MPMarina Paola
11Skrap MMiran
12Zagonel VVittorina
13Lombardi GGiuseppehttps://orcid.org/0000-0003-1316-2132

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA Mismatch RepairMajor topic
DNA-Binding ProteinsMajor topic
GliomaMajor topic
Adult
Aged
Biomarkers, Tumor
Female
Humans
Immunohistochemistry
Male
Middle Aged
Prognosis
Retrospective Studies

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135427471
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Lancet Oncol2022https://conductscience.org/library/papers/35427471PubMed
228371827Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.Neuro Oncol2017https://conductscience.org/library/papers/28371827PubMed
321425258Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.Int J Cancer2011https://conductscience.org/library/papers/21425258PubMed
430514778Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma.Clin Cancer Res2019https://conductscience.org/library/papers/30514778PubMed
531480372Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment.Cancers (Basel)2019https://conductscience.org/library/papers/31480372PubMed
620223108The expression of mismatch repair proteins MLH1, MSH2 and MSH6 correlates with the Ki67 proliferation index and survival in patients with recurrent glioblastoma.Neurol Res2010https://conductscience.org/library/papers/20223108PubMed
719584161MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.Clin Cancer Res2009https://conductscience.org/library/papers/19584161PubMed
829020592First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.N Engl J Med2017https://conductscience.org/library/papers/29020592PubMed
910362805High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.Am J Pathol1999https://conductscience.org/library/papers/10362805PubMed
1028596308Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.Science2017https://conductscience.org/library/papers/28596308PubMed
1131765263Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study.J Clin Oncol2020https://conductscience.org/library/papers/31765263PubMed
1232823925Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study.Cancers (Basel)2020https://conductscience.org/library/papers/32823925PubMed
1326028255PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.N Engl J Med2015https://conductscience.org/library/papers/26028255PubMed
1432437507Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.JAMA Oncol2020https://conductscience.org/library/papers/32437507PubMed
1532051040The efficacy of DNA mismatch repair enzyme immunohistochemistry as a screening test for hypermutated gliomas.Acta Neuropathol Commun2020https://conductscience.org/library/papers/32051040PubMed
1630813960The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion.J Immunother Cancer2019https://conductscience.org/library/papers/30813960PubMed
1731682550Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.J Clin Oncol2020https://conductscience.org/library/papers/31682550PubMed
1829355075Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.J Clin Oncol2018https://conductscience.org/library/papers/29355075PubMed
1919228619IDH1 and IDH2 mutations in gliomas.N Engl J Med2009https://conductscience.org/library/papers/19228619PubMed
2027157931The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.Acta Neuropathol2016https://conductscience.org/library/papers/27157931PubMed

See all 21 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42511857Divergent Roles of Canonical and Non-Canonical Mismatch Repair in Regulating Temozolomide Sensitivity in Glioblastoma.Int J Mol Sci2026https://conductscience.org/library/papers/42511857PubMed
42416056Identification and validation of biomarkers related to mismatch repair for prognosis prediction in glioma.Front Immunol2026https://conductscience.org/library/papers/42416056PubMed
42344520The relationship between DNA damage and repair and the occurrence and development of disease.Front Genet2026https://conductscience.org/library/papers/42344520PubMed
41615212Overcoming Intrinsic and Acquired Temozolomide Resistance in Glioblastoma: Fisetin as a Potential Strategy to Enhance Sensitivity via ZEB1 Modulation.Turk J Pharm Sci2026https://conductscience.org/library/papers/41615212PubMed
41395548
Comparative molecular analysis of primary and recurrent pleomorphic xanthoastrocytoma with BRAF mutation treated with combination therapy with dabrafenib and trametinib: a case report and literature review.
Int Cancer Conf J2025https://conductscience.org/library/papers/41395548PubMed
41340766Mismatch Repair Deficiency in Gliomas: A Rare Insight into Microsatellite Instability and Its Diagnostic Implications.Asian J Neurosurg2025https://conductscience.org/library/papers/41340766PubMed
41233526Huntington disease: somatic expansion, pathobiology and therapeutics.Nat Rev Neurol2026https://conductscience.org/library/papers/41233526PubMed
40302099Correlation between Isocitrate Dehydrogenase Mutation and Immunohistochemical Expression of DNA Mismatch Repair Proteins in the Prognosis of Gliomas.Asian Pac J Cancer Prev2025https://conductscience.org/library/papers/40302099PubMed
38897003Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity.DNA Repair (Amst)2024https://conductscience.org/library/papers/38897003PubMed
38786078Prime Editing and DNA Repair System: Balancing Efficiency with Safety.Cells2024https://conductscience.org/library/papers/38786078PubMed
38749429Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease.Am J Hum Genet2024https://conductscience.org/library/papers/38749429PubMed
37529690Characteristics of glioblastomas and immune microenvironment in a Chinese family with Lynch syndrome and concurrent porokeratosis.Front Oncol2023https://conductscience.org/library/papers/37529690PubMed
35865481PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma.Front Oncol2022https://conductscience.org/library/papers/35865481PubMed
35332262Molecular landscape of pediatric type IDH wildtype, H3 wildtype hemispheric glioblastomas.Lab Invest2022https://conductscience.org/library/papers/35332262PubMed
34944798Sustained Accumulation of Blood-Derived Macrophages in the Immune Microenvironment of Patients with Recurrent Glioblastoma after Therapy.Cancers (Basel)2021https://conductscience.org/library/papers/34944798PubMed
34848827Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.Lab Invest2022https://conductscience.org/library/papers/34848827PubMed
34638714Prognostic and Predictive Biomarkers in Gliomas.Int J Mol Sci2021https://conductscience.org/library/papers/34638714PubMed
34620200Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes.J Hematol Oncol2021https://conductscience.org/library/papers/34620200PubMed
33375286Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives.Cancers (Basel)2020https://conductscience.org/library/papers/33375286PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32937743

GET https://conductscience.org/api/papers/v1/32937743/references?page=2